---
title: "69 Growth-stage Medtech Investors in the US (Nov 2026)"
last_updated: "2026-11-06"
rows: "69"
free_rows: "25"
source: "SEC filings"
canonical: "https://theinvestordatabase.com/lists/growth-medtech-investors-us/"
---

# 69 growth-stage medtech investors in the US

We list 69 growth-stage medtech investors in the US as of November 2026: each has an SEC filing on file, and the list was last checked on 6 Nov 2026. The cities with the most head offices on this list are New York (9), Boston (5) and Menlo Park (4).

- 69 investors
- 33 with a fund filing or dated deal in the last 12 months
- $150M median fund size on file (SEC Form D, 45 firms)
- 383 named decision-makers on file

## First 25 of 69 growth-stage medtech investors in the US

| Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile |
|---|---|---|---|---|---|---|---|---|
| JSTAR Capital | VC firm | Austin, TX | Growth | Medtech, Healthtech, AI, Fintech | New fund, Aug 2026 | $100M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/jstar-capital/ |
| Town Hall Ventures | VC firm | New York, NY | Growth | Medtech, Healthtech, Impact | New deal, Sep 2026 | $400M (SEC Form D, 2025) | 2026-11-05 | https://theinvestordatabase.com/investors/town-hall-ventures/ |
| Echo Health Ventures | Corporate VC | Durham, NC | Growth | Medtech, Healthtech | Portfolio news, Sep 2026 | $518M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/echo-health-ventures/ |
| Longitude Venture Partners | VC firm | Menlo Park, CA | Growth | Medtech, Healthtech, Biotech | New deal, Jun 2026 | $600M (SEC Form D, 2022) | 2026-11-05 | https://theinvestordatabase.com/investors/longitude-venture-partners/ |
| MVM Partners LLP | VC firm | Boston, MA | Growth | Medtech, Healthtech, Biotech | Portfolio news, Jun 2026 | $1.0B (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/mvm-partners-llp/ |
| Khosla Ventures | VC firm | Menlo Park, CA | Pre-seed, Seed, Series A, Growth | Medtech, AI, Consumer, B2B | New fund, Aug 2026 | $1.9B (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/khosla-ventures/ |
| Bioventures Investors | VC firm | Westborough, MA | Growth | Medtech, Healthtech, Future of Work, Fintech | New deal, Apr 2025 | $350M (SEC Form D, 2020) | 2026-11-05 | https://theinvestordatabase.com/investors/bioventures-investors/ |
| Transformation Capital | VC firm | Boston, MA | Growth | Medtech, Healthtech | New fund, Sep 2026 | $800M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/transformation-capital/ |
| Treo Ventures | VC firm | Reno, NV | Growth | Medtech, Healthtech | Portfolio news, Apr 2025 | $150M (SEC Form D, 2022) | 2026-11-05 | https://theinvestordatabase.com/investors/treo-ventures/ |
| Portfolia | Fund manager | San Mateo, CA | Growth | Medtech, Healthtech, Media, Fintech | New fund, Apr 2026 | $6M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/portfolia/ |
| NewVale Capital | VC firm | Boulder, CO | Growth | Medtech, Biotech, Healthtech | New fund, Oct 2026 | $250M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/newvale-capital/ |
| Quartus | VC firm | New York, NY | Growth | Medtech, AI, Healthtech, B2B | New fund, Sep 2026 | $150M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/quartus/ |
| HLM Investment Partners | VC firm | Waltham, MA | Growth | Medtech, Healthtech | New fund, Aug 2026 | $61M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/hlm-investment-partners/ |
| Accelmed | VC firm | Aventura, FL | Growth | Medtech, Healthtech, Developer Tools, Biotech | Portfolio news, Apr 2026 | $401M (SEC Form D, 2021) | 2026-11-05 | https://theinvestordatabase.com/investors/accelmed/ |
| Arcventis Health Partners | VC firm | New York, NY | Growth | Medtech, Healthtech, Biotech | New fund, Sep 2026 | $33M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/arcventis-health-partners/ |
| Claritas Signal Partners | VC firm | Nashville, TN | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Media | New deal, Aug 2026 | $14M (SEC Form D, 2021) | 2026-11-05 | https://theinvestordatabase.com/investors/claritas-signal-partners/ |
| Sana Capital | VC firm | New York, NY | Growth | Medtech, Healthtech | New fund, Apr 2026 | $100M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/sana-capital/ |
| Ansa | VC firm | New York, NY | Series A, Series B, Growth | Medtech, AI, Cybersecurity, Healthtech | New fund, May 2026 | $200M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/ansa/ |
| Sprig Equity | VC firm | Wilmette, IL | Growth, Late stage | Medtech, Healthtech | New fund, Aug 2026 | $34M (SEC Form D, 2023) | 2026-11-05 | https://theinvestordatabase.com/investors/sprig-equity/ |
| Eckuity Capital | VC firm | New York, NY | Growth | Medtech, Healthtech, Biotech | New fund, Jun 2026 | $300M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/eckuity-capital/ |
| Aliment Capital | VC firm | Los Angeles, CA | Growth | Medtech, Healthtech, Food and Beverage, Agritech | Portfolio news, Mar 2026 | $413M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/aliment-capital/ |
| Adams Street Growth Equity | Fund manager | Chicago, IL | Growth | Medtech, SaaS, Fintech | New fund, Apr 2026 | $167M (SEC Form D, 2023) | 2026-11-04 | https://theinvestordatabase.com/investors/adams-street-growth-equity/ |
| Star51 Capital | VC firm | New York, NY | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Robotics | New deal, Sep 2026 |  | 2026-11-04 | https://theinvestordatabase.com/investors/star51-capital/ |
| Sandbox Clinical Ventures | VC firm | Chicago, IL | Seed, Series A, Series B, Growth | Medtech, Insurtech, Healthtech, AI | New fund, Sep 2026 | $100M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/sandbox-clinical-ventures/ |
| Roo Capital | VC firm | Coconut Grove, FL | Pre-seed, Seed, Series A, Growth | Medtech, AI, Healthtech, Future of Work | New fund, Aug 2026 | $125M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/roo-capital/ |

You are seeing 25 of 69. The full list adds 44 more investors and 383 named decision-makers.

Get all 69 investors and 383 named contacts, $49, one-time: https://theinvestordatabase.com/buy/list/growth-medtech-investors-us
This page: https://theinvestordatabase.com/lists/growth-medtech-investors-us/

## Method and limits
- Source: All 69 rows carry an SEC filing (Form D or Form ADV). All 69 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states medtech and medical devices as a focus on its own site, or we observed it in the firm's portfolio. Stage: the firm states that it invests at growth-stage.
- Order: Activity score out of 100: recency of the latest fund filing or dated deal (30: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (20; half of that when the sector is stated only), stage focus (15: all of it when growth-stage is the only stage the firm states, split evenly when it states more), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (12) and completeness of the public record (8). Stage and regional focus are our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Fill rates: Of 69 rows: stage 69, sector 69, fund size 61, website 69. In the paid file: named decision-makers on 64 rows, firm email on 25, LinkedIn page on 41, check size on 6.

## Questions
### How many growth-stage medtech investors in the US are there?
We list 69 as of November 2026. 33 of the 69 have a fund filing or a dated deal in the last 12 months. The cities with the most are New York (9), Boston (5) and Menlo Park (4).

### Which growth-stage medtech investors in the US raised a new fund in the last 12 months?
21 of the 69 have a fund filing dated in the last 12 months. The most recent on this list are IVP: Venture capital for the Exceptional (Oct 2026), NewVale Capital (Oct 2026) and Transformation Capital (Sep 2026).

### What is the typical fund size of growth-stage medtech investors in the US?
The median fund size on file for this list is $150M, across the 45 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 24 do not disclose a size there.

### How do I contact growth-stage medtech investors in the US?
The paid file holds 383 named decision-makers across 64 of these 69 and a firm email for 25. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.

### Where does the data on growth-stage medtech investors in the US come from?
All 69 rows have an SEC filing on file (Form D or Form ADV). Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 6 Nov 2026 at the latest. The whole file is re-verified twice a year.